Literature DB >> 12842843

Macrophage-specific p53 expression plays a crucial role in atherosclerosis development and plaque remodeling.

Aksam J Merched1, Elizabeth Williams, Lawrence Chan.   

Abstract

OBJECTIVE: We first showed that absence of p53 accelerates atherosclerosis development in apoE-deficient mice. In this study, we investigated how macrophage-specific loss of p53 function might modulate atherosclerosis development in LDL receptor-deficient mice, a model for familial hypercholesterolemia. METHODS AND
RESULTS: We transferred bone marrow cells isolated from p53+/+ and p53-/- mice to lethally irradiated LDL receptor-/- mice and evaluated the aortic atherosclerotic lesion areas in the recipients at different times afterward. At 15 weeks and again at 20 weeks, we found larger aortic lesion size in mice receiving p53-/- cells compared with those that received p53+/+ cells. By measuring the rate of bromodeoxyuridine incorporation, we found that the absence of p53 in macrophages stimulates cellular proliferation. In contrast, the rate of apoptosis in the atheromatous lesion was similar in the two groups of mice. Furthermore, we found that the absence of macrophage-specific p53 expression was associated with vulnerable-appearing lesions marked by increased tissue necrosis and reduced collagen deposition.
CONCLUSIONS: p53 plays a crucial role in atherosclerosis lesion development and remodeling, and macrophage-specific p53 deficiency stimulates cellular proliferation leading to a vulnerable-appearing phenotype of lesions in a mouse model of familial hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842843     DOI: 10.1161/01.ATV.0000084825.88022.53

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  34 in total

1.  LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity.

Authors:  Gengze Wu; Jin Cai; Yu Han; Jinghai Chen; Zhan-Peng Huang; Caiyu Chen; Yue Cai; Hefei Huang; Yujia Yang; Yukai Liu; Zaicheng Xu; Duofen He; Xiaoqun Zhang; Xiaoyun Hu; Luca Pinello; Dan Zhong; Fengtian He; Guo-Cheng Yuan; Da-Zhi Wang; Chunyu Zeng
Journal:  Circulation       Date:  2014-08-25       Impact factor: 29.690

Review 2.  Pathologies associated with the p53 response.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-07       Impact factor: 10.005

3.  p53 is required for chloroquine-induced atheroprotection but not insulin sensitization.

Authors:  Babak Razani; Chu Feng; Clay F Semenkovich
Journal:  J Lipid Res       Date:  2010-03-05       Impact factor: 5.922

4.  Physical and functional antagonism between tumor suppressor protein p53 and fortilin, an anti-apoptotic protein.

Authors:  Yanjie Chen; Takayuki Fujita; Di Zhang; Hung Doan; Decha Pinkaew; Zhihe Liu; Jiaxin Wu; Yuichi Koide; Andrew Chiu; Curtis Chen-Jen Lin; Jui-Yoa Chang; Ke-He Ruan; Ken Fujise
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

5.  Myeloid p53 regulates macrophage polarization and venous thrombus resolution by inflammatory vascular remodeling in mice.

Authors:  Subhradip Mukhopadhyay; Toni M Antalis; Khanh P Nguyen; Mark H Hoofnagle; Rajabrata Sarkar
Journal:  Blood       Date:  2017-03-20       Impact factor: 22.113

6.  Fortilin reduces apoptosis in macrophages and promotes atherosclerosis.

Authors:  Decha Pinkaew; Rachel J Le; Yanjie Chen; Mahmoud Eltorky; Ba-Bie Teng; Ken Fujise
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-16       Impact factor: 4.733

7.  p53 is renoprotective after ischemic kidney injury by reducing inflammation.

Authors:  Timothy A Sutton; Takashi Hato; Erik Mai; Momoko Yoshimoto; Sarah Kuehl; Melissa Anderson; Henry Mang; Zoya Plotkin; Rebecca J Chan; Pierre C Dagher
Journal:  J Am Soc Nephrol       Date:  2012-12-06       Impact factor: 10.121

8.  GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions.

Authors:  Su-Ning Zhu; Mian Chen; Jenny Jongstra-Bilen; Myron I Cybulsky
Journal:  J Exp Med       Date:  2009-09-14       Impact factor: 14.307

Review 9.  Nutrigenetics and nutrigenomics of atherosclerosis.

Authors:  Aksam J Merched; Lawrence Chan
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

10.  Beta2 integrins modulate the initiation and progression of atherosclerosis in low-density lipoprotein receptor knockout mice.

Authors:  Aksam Merched; Katherine Tollefson; Lawrence Chan
Journal:  Cardiovasc Res       Date:  2009-10-20       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.